In this phase 2 study, 212 eligible subjects (13.6% of those screened) were randomized to 24 weeks of pemvidutide 1.2 mg ( n = 41), 1.8 mg ( n = 85), or placebo ( n = 86) stratified by fibrosis (F2 or F3) and presence/absence of T2DM
That doesnt make those improvements any less real or important
Available tablet doses are 1.5 mg, 4 mg, 9 mg, and 25 mg and injection doses are available as 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, 2.4 mg per 0.5 mL
Everything happens online Your couch is now your doctors office
Heisterkamp, N., Groffen, J., Warburton, D